En
  • En
  • Ru
  • Kr
  • Jp
  • Cn
  • Fr
  • It
  • De
  • Sp
  • Pt
  • Tr
  • Pl
  • Ar
  • Ph
  • Id
  • Hi
  • Nl
  • Vi
  • Cs
  • Gr
  • Ro
  • Hu
  • Dk
  • He
  • Hr
  • Sr
  • Lv
Sign in Sign up
#Blockchain, #Healthcare All projects

Aimedis: The future of healthcare

Aimedis is the only operational platform to integrate latest blockchain technology alongside artificial intelligence (AI)

stage Ended crowdsale

3.9 Rating

by 7 users


    KPLs

    • Employees17

    Traction

    June, 2017

    Launch of Aimedis 1.0 in closed environment

    October, 2017

    Getting Certified ISO 9001 & ISO 27001

    October, 2017

    Start of European cooperations SRH hospital group 1.


    Team

    17

    Dr. Michael J. Kaldasch

    CEO, MD & founder

    Dr. Ben El Idrissi

    CEO, MD & founder

    Sankar Ghanesh

    CTO

    Dr. Lazaros Fountoukidis

    CMO & MD

    Roxana Nasoi, M.Sc

    CCO

    Dr. Stefan F. Krieg

    Physicist - HPC, deep learning & AI

    Lin Wan, M.Sc.

    Head of IT & development

    Amer Mufti

    Head of Silicon Valley office - lead blockchain development

    Sebastian Wehkamp, M.A.

    CDO & creative director

    Benjamin Bergmann

    CSO

    Sopia Singdee

    BD Asia

    Daria Borisenko, B.A.

    BD Russia, Belarus & Ukraine

    BingFeng Liu, B.Sc.

    Full stack developer

    ZiLong Sun, B.Sc.

    Full stack mobile developer

    Markus Moench, M.Sc, B.Sc.

    Full stack developer

    Gang Zhu, B.Sc.

    Full stack developer

    Dr. Yang Chul Boering

    Projectleader cardiology & MD


    Advisors

    10

    Prof. Dr. Volker Hömberg

    Neurologist, president WFNR

    Prof. Dr. Maximilian Mehdorn

    Neurosurgeon

    Prof. Dr. Hartmut Gülker

    Cardiologist

    Prof. Dr. Thomas Druyen

    Director of the Institute for Future Psychology and Future Management

    Prof. Dr. Michael Philippi

    Former CEO Sana Kliniken AG

    Prof. Dr. Georg Sabin

    Cardiologist

    Prof. Dr. Hubertus Heuer

    Cardiologist

    Prof. Dr. Berhard Breil

    Health IT scientist

    Prof. Simon Choi, LLB, LLM, CPEC

    Top global ICO lawyer

    Prof. Dr. Timo Schinkoethe

    Biologist & Computer scientist, founder of Cankado




    Crowdsale details

    Distribution of tokens
    • Crowdsale (50%)
    • Community initiatives, marketing & legal (20%)
    • Team, supporters & advisory board (20%)
    • Legal reserve (5%)
    • Reserve (5%)
    Budget allocation
    • Development ($57)
    • Operations ($16)
    • Merketing ($13)
    • Reserves for buyback ($8)
    • Legal ($6)
    Details Indicators
    Token Symbol AIM
    Full Token Name AIM Token
    Pre-crowdsale Start April 12th, 00:00 GMT+03:00
    Pre-crowdsale End July 10th, 00:00 GMT+03:00
    Crowdsale Start August 1st, 00:00 GMT+03:00
    Crowdsale End Hard cap is reached or August 31st, 00:00 GMT+03:00
    Crowdsale Hard Cap Fixed, 600000000 BTC
    Token type utility token
    Domain registration date 2017-03-14
    Domain owner Identity Protection Service, Identity Protect Limited, PO Box 786, Hayes, Middlesex, UNITED KINGDOM

    Cost of the token

    1 token for 0.12 $

    Price without discounts

    Discounts and Bonuses

    Token holders will participate in the profits Aimedis generates

    Pre-crowdsale
    Discount Dates Minimum purchase amount
    20% April 04 — October 10, 2018

    Accepted currency

    • Ethereum


    Rate the project

    Estimate the project on a five-point scale or switch to the simple scale

    Five-point scale Simple scale

    Relevance of the problem and Market size

    1 2 3 4 5

    Product competitiveness

    1 2 3 4 5

    Founders, Team & Advisors

    1 2 3 4 5

    Budget allocation and roadmap

    1 2 3 4 5

    Token economy, Tokenization & Business model

    1 2 3 4 5

    Distribution & Lock up of tokens, Discounts for early buyers

    1 2 3 4 5

    Summary rate the project

    1 2 3 4 5

    Rate the project by other users

    7
    John Wiener May 23, 2018
    Rating of project
    4.5

    Advantages

    Seems to have all the advantages a modern ehealth system needs to handle including social media. Solves two major issues - centralization and non-incentivizing of participants. Connects to professional health IT and already is a working product.

    Risks and disadvantages

    Competitors, though I didn't find one that has all the things Aimedis does. Different medical markets, different problems. But good team with international experiences.

    Comments

    Will invest into Aimedis, think it is one of the best healthcare ICOs so far.

    William Anderson April 13, 2018
    Rating of project
    3.0

    Advantages

    The latest blockchain technology alongside artificial intelligence (AI) that are being used to propagate this start up are next level sophisticated technology that provides efficiency in task delivery this obviously a competitive advantage from the other existing competitors. With the growing populations all over and constant movement this particular platform could provide effective an useful help on quick diagnosis and first help which is first staid in the absence of a medical personnel which will contribute to saving lives.

    Risks and disadvantages

    The founder team of this venture luck experience in cryptocurrency and blockchain technology it will be rather difficult for them to cope with competitors that have experience already in this way this particular start up is not profitable to the investors because it has high risk involved, It has also come to my notice that the persons responsible for the establishment of effective awareness campaigns have so reluctant, if the investors are not made aware of the investment opportunity chances are the they wouldn't know and also wouldn't invest , on the side of the start up its a problem.

    Comments

    With the fact that this venture has a competitive advantage that is already a consolidated ground for it to obtain and win a large market share this can however be obtained through effective awareness strategies and market research, also investors should be given priority so as to increase on their in flow and not out flow. The team will never the less need guidance from experienced people in the filled of cryptocurrency.

    Alexandr Gonchar April 05, 2018
    Rating of project
    4.2

    Advantages

    Using an artificial intelligence and blockade technology in the medical industry gives great advantages, it's the ability to track counterfeit meds, the correctness of the diagnosis, dosage and other important things.

    Risks and disadvantages

    The project has many competitors; therefore for a successful ICO, it is necessary to conduct a proper advertising campaign and show the advantages of its solutions correctly.

    Comments

    If the project succeeds in attracting large producers of electronic chips and to implement all its solutions, it's possible that this medical project will be one of the best in this segment.

    Veronika Arbisman April 03, 2018
    Rating of project
    4.5

    Advantages

    Solution designed to connect patients with healthcare services and providers. Is an operational platform. Amazing traction list. Platform is aimed to resolve all pharmacy-related problems. Video library will provide medical content both educational and therapeutic directions. Medical social media platform where patients can support each other.

    Risks and disadvantages

    Massive field and massive project. Need really good implementation strategy on long and short-term planning. Is a huge challenge, specially in law regulations and restrictions. Better to divide it into stages.

    Comments

    Really huge number of advantages. Starting from picking the correct dosage, cross-checking of prescribed medications, tracking the medications from point of origin to an end user up to providing possibilities for hospitals and doctors to develop new revenue streams. Also gives an opportunity for pharma companies to cut their money and reputation loses. Excellent application for chronic patients. Gives on top of all possibility for pharmacies as well, for example to arrange delivery of medicals. Amazing idea for developed medical markets such as US and Europe.

    Ladislava Chernik April 03, 2018
    Rating of project
    3.2

    Advantages

    In top management there are many doctors and medical managers. Believe that they are familiar with the real demands of this sector

    Risks and disadvantages

    Possible regulation problems.
    It's not very clear why they need to use blockchain, not just secure databases

    Comments

    I did not see any new proposal, ideas - a lot of similar projects are already on the market. And even a public relations specialist admits that their team is new to the market

    Sofia Medda March 30, 2018
    Rating of project
    4.2

    Advantages

    The idea of the project is very challenging. I think if the team can reach all these goals, the project will become great and famous. There are some of the goals which seems to be reached easier than the others (medical content, medical network, diagnoses and research).
    The team already has a product in operation.
    AI supported therapy is a promising idea.

    Risks and disadvantages

    Realization of some goals (remote health care and tracking a medicine from the point of origin until it is prescribed to an end user) can be difficult and require time. Clinics, drugstores and maybe even manufacturers should be involved.

    Comments

    The project is huge, it has many goals. Maybe it has sense to connect with team and ask more about the realization strategy.

    Jordan Semanda March 28, 2018
    Rating of project
    4.0

    Advantages

    Provides remote healthcare to people in distant places. The token value has an excellent price The crowd sales are high which is good for future price token. The project can easily be adopted by many computer systems Its an efficient platform for sharing content and storing it in the libraries. It makes the storage of data efficient and confidential in the blockchain. It has an AI supported system which solves pharmaceutical related issues. sharing subjective experiences with other patients will help others go through tough times.e

    Risks and disadvantages

    The project has extremly low traffic in the internet interaction. The market is however competitive from ICO project like ehealth. Many people don't have knowledge about medication and self medication. The target market might not be ready for the changes.

    Comments

    The initiative is good and will have a beak through on the market however marketing strategies have to be implemented inoder to secure a satisfactory market share. The project is free which makes it easily adoptable to many users that will in the end increase the token value. Health is an amenity that is needed by lots of people all over the globe. The project provides better health services for many and will also improve on the life expectancy.

    See more reviews

    FAQ

    Frequently Asked Questions

    Where is Aimedis based?

    Aimedis is based in the Netherlands and Switzerland to meet the highest regulatory standards and security for both users and investors.

    Why a blockchain?

    Storing medical data in highly encrypted and secured databases grants an added level of security, transparency and efficiency of transfer. The core principles the blockchain is built on are well suited for the transfer of health data as they achieve a multi-purpose environment, which existing solutions cannot guarantee. Our proprietary AIMChain is a testament to this. Every single operation, every single access to patients’ data, every change can be tracked and is 100% traceable for patient and medical professionals – inside the platform – patients can see in a diagram when, where and why a doctor or a hospital has accessed their data and what changes have been made. That is the AIMChain!

    Another medical ICO? Why should I invest in Aimedis?

    In contrast to a lot of competitors in general and especially in the medical field we offer a fully working platform and not just an idea. Based on our 2012 developed Platform TheHealthNet/IhrArzt24 (rolled out in Germany and German speaking countries) which worked as our experimental platform for 3 years we gathered information and experience working with institutions and patients. In addition we rely on our well-developed network of connections in Europe emphasizing that the Aimedis founder worked in Germany and France for years which are the biggest health care markets in Europe. Since last year we are focusing on Asia and concentrating in building a powerful network which will help us grow in Asian countries.

    Where will Aimedis operate its business?

    Aimedis operates its business in the Netherlands, Switzerland, Germany and Thailand but will expand to more countries in the next 2 years. We are already operating a development office in Mountain View, Silicon Valley to be close its unique entrepreneurial and development spirit.

    What role will artificial intelligence play?

    Artificial intelligence (AI) will, and already is, revolutionizing the way we live, work and succeed. Medicine is one of the major use cases for AI where it will improve diagnoses, therapies and research at a level, no human being can reach. Even today AI can diagnose CT and MRI images much better than the best medical professionals. In future, AI will be a major part of the way our medical ecosystem will enhance patients’ and doctors’ lives. Initially AI will support doctors when it comes to enhancing medication, recognizing possible drug interactions and optimizing dosage regarding sex, age, weight, diagnoses (e.g. kidney failure) and in a later stage pharmacogenetic predispositions (e.g. slow vs. rapid metabolizers). AIMedibots will continually crawl the anonymous parts of our secured databases to gather new insights, for e.g. on unknown possible drug interactions or side effects regarding certain diagnoses and conditions. The larger our database the more significance the gathered information will have. As we start our cooperation with several hospital chains in a short time, we will grow our database quickly and AI will have quite some work to do. In a later stage, Aimedis V3.0 project Excalibur, Aimedis will introduce AI supported diagnoses and therapies in cooperation with university hospitals.

    AIM token sale details

    How many AIM tokens will be distributed with the tokensale?

    There will be 600.000.000 AIM token in total, from which 300.000.000 will be distributed in the AIM token sale. Any amount exceeding the target will be returned to the participating ETH wallet after the tokensale process has ended.

    What will be the value of the AIM token after the tokensale has ended?

    The value of the AIM token after the ICO can’t be predicted now and will be determined by the market evaluation which is the case in most ICOs in the cryptomarket.

    What is going to happen if the scheduled tokens are not sold in total?

    If the full 300.000.000 tokens are not sold during the ICO, only the sold amount of AIM token will be issued and the remaining ones will be burned so the total amount of existing tokens depends on the results of the ICO.

    Who can participate in the AIM token sale?

    Anyone can participate in AIM’s tokensale. Before taking part please make sure you are eligible to participate in the Aimedis tokensale depending on your jurisdiction. In general, residents of the United States and Singapore can’t participate in tokensales. Even if you are not a resident of United States and Singapore, please be sure to check if there are any regulatory restrictions in your country or state.

    The AIM token sale process

    How and where can I get AIM token during the presale and main ICO?

    To participate in the AIM token sale, please sign up to our newsletter and our social media channels to be updated on a regular base. When the presale has started you will find a unique ETH address you can send ETH to. Another ETH address will be shown on the ICO landing page during the main ICO. The settings for the presale and sale (GAS etc.) will stay the same for pre-ICO and ICO. After completion your tokens can be recived via etherscan.io.

    How do I buy Ethereum?

    Ethereum can be purchased on a lot of cryptocurrency exchanges. Please visit coinmarketcap.com for more information.

    What’s the minimum amount to contribute and what happens if I contribute less than the minimum amount?

    The minimum amount to contribute equals to 0.1 ETH. If you send less than 0.1 ETH the amount will be refunded to the original ETH address in full.

    How are AIM tokens distributed and allocated?

    AIM tokens will be distributed and allocated in the order of the transactions received from the specified address. The tokens are distributed to ERC20 and can be received immediately upon completion of the participation.

    How many AIM tokens do I get for 1 ETH?

    This will depend on the actual value of ETH, 1 AIM = 0,12 USD

    What happens if you contribute your ETH to the wrong ETH address by mistake?

    Unfortunately it is not possible to return ETH once it’s send to a specific address so you have to make sure you check the correct ETH address before you send it. The exact ETH address to contribute to will be displayed ONLY on our ICO page (aim.aimedis.com). No other website will show the ETH address so any address that differs from the one shown on aim.aimedis.com is NOT ours. Aimedis is NOT responsible for lost ETH and will not refund them.

    Can I get a refund after having contributed?

    There is no separate refund process except in the case where the fundraised amount exceeds the maximum amount.

    The AIM token

    When can AIM token be traded on crypto exchanges?

    Aimedis plans to list the AIM token in several exchanges, so please stay tuned for more information coming up after the ICO.

    When will the AIM wallet be available?

    The AIM token wallet will be available soon after the ICO. We will also announce it on our social media channel.


    or

    or